Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome
18/09/2023 12:12
Sept 18 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS INC - REPORTS RESULTS IN ALL
PATIENTS
TREATED WITH ELX-02 IN PHASE 2 CLINICAL STUDY FOR ALPORT
SYNDROME
Source text for Eikon: ID:nGNX4gvpXR
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))